Last reviewed · How we verify
NCT05178459: WISUDO
Withings Study to Analyse the Accuracy of Screening Small Fiver Neuropathy With a Bathroom Scale
trial testing Neuropathy measurement in Neuropathy in 177 participants. Completed in 8 August 2022.
22 July 2022
Quick facts
| Lead sponsor | Withings |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 177 |
| Start date | 11 March 2022 |
| Primary completion | 22 July 2022 |
| Estimated completion | 8 August 2022 |
| Sites | 4 locations across France |
Drugs / interventions tested
- Neuropathy measurement
Conditions studied
- Neuropathy — all drugs for Neuropathy →
Sponsor
Withings — full company profile →
Who can join
18 and older, any sex, with Neuropathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to evaluate the diagnostic performance of Withings WBS08 to screen small fiber neuropathy.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Validation of the Body Scan<sup>®</sup>, a new device to detect small fiber neuropathy by assessment of the sudomotor function: agreement with the Sudoscan<sup>®</sup>.
Riveline JP, Mallone R, Tiercelin C, Yaker F, et al · · 2023 · cited 6× · PMID 38020587 · DOI 10.3389/fneur.2023.1256984
Verify or expand the search:
- PubMed search for NCT05178459
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Neuropathy
Currently open trials in the same condition.
- NCT07390279 — Efficacy of Transcutaneous Pulsed Radiofrequency in Postherpetic Neuralgia · recruiting
- NCT07390617 — A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma · recruiting
- NCT06807294 — Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT) · NA · recruiting
- NCT06837181 — Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM) · recruiting
- NCT06912646 — Clinical Efficacy of the Erchonia EVRL for Providing Temporary Relief of Idiopathic Peripheral Neuropathy Foot Pain · NA · recruiting
Other Withings trials
Trials by the same sponsor.
- NCT06957847 — Clinical Validation of the Blood Pressure Measuring Device Withings BPM Pro 2 (WIHYP-GP) · NA · completed
- NCT06692413 — Withings Devices Follow-up Study - Hypertension · withdrawn
- NCT06351761 — WIBOFA - Validation of SCT02 With ECG-App for Detection of AF · NA · completed
- NCT05823025 — Withings Study to Analyze the Accuracy of Pulse Wave Velocity Measurement With Bathroom Scales (WIVOP-Scales) · active not recruiting
- NCT05316337 — Withings ECG-Monitor Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05178459 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Withings
- Last refreshed: 25 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05178459.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing